Latest on Prebiotics Industry

  • Analysis
  • 08-March-2019

Prebiotics market is expected to gain a high growth in the years to come owing to rising awareness regarding the health benefits of prebiotic ingredients across consumers. Also, increasing usage of prebiotics in several dairy products along with the advent of new ingredients such as Xylo-Oligosaccharides (XOS), with enhanced functional properties will increase the scope of application of prebiotic in food products. Further rising usage of prebiotics ingredient to treat gastrointestinal disorders, such as constipation and Irritable Bowel Syndrome (IBS) is also anticipated to augment the market growth. Below are some of the recent market developments that have been observed in the market:

Jennewein and Yili has signed a contract to produce innovative dairy infant formula

Jennewein Biotechnologie GmbH and Inner Mongolia Yili Industrial Group recently announced that they have signed a Memorandum of Understanding on infant microbiome and human milk oligosaccharides, to develop a novel infant formula and dairy products specifically for the Chinese market. HMO act as prebiotics for the production of the infant microbiome. HMOs has been seen to have third-largest constitute of breast milk and possess various health benefits and also protect the human body against infectious diseases (e.g. noroviruses).
Kellogg has recently released cereal that promotes good health to the digestive system

Hi! Happy Inside” is a new wellness brand of Kellogg that is supposed to promote good health to human digestive system. The three variety of cereals included in this product features prebiotics, probiotics, and fiber. This is available in three flavors that are coconut crunch, strawberry, and blueberry. The introduction of this product has added one more healthy option for the growth health conscious customers.
Microbiome Venture established by DuPont in order to develop New Microbiome Science-Based Solutions

DuPont has announced that it has established new microbiome venture for the development of new microbiome science-based solutions. With this Microbiome Venture, they are planning to develop new microbiome science-based solutions for the wellness of digestive human digestive system. This venture investment is expected to complement company’s current product portfolio, in terms of probiotics, prebiotics, and human milk oligosaccharides products.

Companies respond to changing consumer preference on priority to get a first’s mover’s benefits. Below are some related market research reports to enrich market understanding -